Novel pharmacologic treatment options reduce mortality and morbidity in a cost-effective manner in patients with heart failure (HF). Undisputedly, the effective implementation of these agents is an essential element of good clinical practice, which is endorsed by the European Society of Cardiology (...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!